ALNY - Alnylam Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.89B
Enterprise Value 310B
Trailing P/E -23.17
Forward P/E 1-22.40
PEG Ratio (5 yr expected) 1-0.51
Price/Sales (ttm)164.99
Price/Book (mrq)9.69
Enterprise Value/Revenue 3151.59
Enterprise Value/EBITDA 6-22.92

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)-680.48%
Management Effectiveness
Return on Assets (ttm)-19.93%
Return on Equity (ttm)-39.86%
Income Statement
Revenue (ttm)66M
Revenue Per Share (ttm)0.76
Quarterly Revenue Growth (yoy)82.90%
Gross Profit (ttm)47.16M
EBITDA -436.51M
Net Income Avi to Common (ttm)-442.72M
Diluted EPS (ttm)-5.12
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)923.27M
Total Cash Per Share (mrq)10.06
Total Debt (mrq)150M
Total Debt/Equity (mrq)13.36
Current Ratio (mrq)8.84
Book Value Per Share (mrq)12.25
Cash Flow Statement
Operating Cash Flow (ttm)-335.25M
Levered Free Cash Flow (ttm)-256.73M

Trading Information

Stock Price History
Beta 3.46
52-Week Change 3230.85%
S&P500 52-Week Change 319.28%
52 Week High 3126.16
52 Week Low 331.38
50-Day Moving Average 3102.43
200-Day Moving Average 378.74
Share Statistics
Avg Vol (3 month) 31.27M
Avg Vol (10 day) 3899.41k
Shares Outstanding 591.73M
Float 76.48M
% Held by Insiders 116.61%
% Held by Institutions 196.35%
Shares Short 38.81M
Short Ratio 311.01
Short % of Float 321.59%
Shares Short (prior month) 39M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A